The global APIs market was dominated by North America, which generated 35.1% of global API revenues in 2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of 29.7% in 2011.
The global APIs market revenues reached $108,613m in 2011. In the product-based segments, the synthetic market dominated the market with 82.7% of global APIs revenues. However, increasing acceptance and increasing penetration are boosting the biopharmaceuticals drug market in both developed and developing economies.
This report provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations (CMO) growth in the region, and their influence on API manufacturing activity towards 2017.
Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
- Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.
- API markets in the regions of North America, Asia-Pacific and Europe, along with key countries such as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK and Spain.
- API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology globally.
- Drivers and restraints for the global APIs market.
- Detailed historical, forecast trend and share analysis of API revenues based on product types (synthetic and biotechnology APIs) at the global, regional and key country levels.
- Detailed historical and forecast trends and share analysis for API revenues based on the customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) at the global, regional and key country levels.
- Analysis of API revenues based on therapeutic categories at a global and regional level.
Reasons to buy
- Develop business strategies with the help with specific insights in the global API market.
- Identify opportunities and challenges in the global API market.
- Invest in the growing segments of the APIs market.
- Increase future revenue and profitability with the help of insights into the future opportunities and critical success factors in the global APIs market.
- Benchmark your operations and strategies against the major players in the global APIs market.